Paolo Benatti / PresidentGraduated in Economics, after 4 years in auditing with Arthur Andersen, he is in health care business since 1985 mainly with Baxter and Sorin. For many years operating in finance, Planning and Control with various increasing responsibilities and then in 2003 moved to general management positions with particular focus on Operations. A wide and international experience in Merger & Acquisitions, re-organizations, cost improvement projects, due diligence and Stock Exchange Listing. Mauro Magnani / Chief Scientific Officer / Prof. AdvisorThe Company’s founder, Prof. Mauro Magnani, Professor of Biochemistry and Director Centre of Biotechnology, Urbino, Italy identified the need in the market of introducing pharmacological agents (drugs, proteins, contrasting agents for diagnostic purposes, nanoparticles, etc.) into erythrocytes (or Red Blood Cells, RBCs) and thus opening new therapeutic strategies thanks to an innovative drug delivery system. He has been: Visiting Researcher, Dept. Biochemistry, Univ. Birmingham, 1980; Visiting Prof. Dept. Biolgy, Haifa, Israel, 1983; Asst. Prof. Univ. Urbino, 1977-82; Assoc. Prof., 1982-1986; Prof. 1986 - ; Dean, Faculty of Sciences University of Urbino 1995-2001; Director Interuniversity Consortium for Biotechnology (CIB) 1998-2004; Vice Rector of the University of Urbino 2001. He was pro-Rector of Urbino University between 2001 and 2009. He is also a “Technical Director” nominated by the “Agenzia Italiana del Farmaco, AIFA” with n. AIDT-19/2005. Co-founder of many start-up companies. He is author of more than 300 articles published in international refereed scientific journals; Co-editor of three books and reviewer for over 30 important peer reviewed Journals (e.g. Biotechnology and Applied Biochemistry; Nature Biotechnology; Drugs; Leukemia; European Journal Haematology) Bruno Brusciotti / AdvisorProf. Bruno Brusciotti is a lawyer and professor of administrative law at the University of Urbino, Italy. He is actually CEO of Focus Gestioni SGR S.p.A., management company of the Focus Impresa fund and part of the Banca Marche Group. He has been President (2000 – 2003) and vice President (2004 -2009) of the Banca Marche Group. Member of board of directors of many industrial and insurance companies in Italy. Luigia Rossi / Co-founder, Prof. AdvisorCo-founder of the company, Prof. Luigia Rossi is mainly interested in the development of new procedures involving the loading of human and mammalian erythrocytes (RBC) with drugs, enzymes, nucleoside analogues, proteins and contrast agents in order to use the engineered RBC obtained as a drug delivery system. Gianfranco RutiliGianfranco Rutili has over 35 years of experience in the pharmaceutical industry covering increasing roles and responsibilities both in basic research and drug development. Most recently he was V.P of Development at Shaman Pharmaceuticals and V.P./Senior Director for Development, Oncology, at Pharmacia and Pfizer. Currently he serves in the Board of Directors in several smaller Italian pharmaceutical companies. Giuseppe Piccinotti From 1975 to 1979 he has undertaken a Teaching & Research assignments in Physics and Astronomy at the University of Milano and CNR. From 1979 to 1980 he was Researcher at NASA’s Goddard Space Flight Center in Greenbelt (MD, USA). |
EryDel SPA |